✦ LIBER ✦

Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity

✍ Scribed by Jack van Hoff; Holcombe E. Grier; Edwin C. Douglass; Daniel M. Green

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 416 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950615)75:12<2966::aid-cncr2820751226>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide, ifosfamide, and cisplatin the

Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors

✍ Jacob Lokich 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Cisplatin and etoposide combination ther

Cisplatin and etoposide combination therapy for primary glial tumors: Preliminary results

✍ A. Boiardi; A. Silvani; I. Milanesi; L. Munari; C. L. Solero; M. Botturi 📂 Article 📅 1991 🏛 Springer Milan 🌐 English ⚖ 403 KB

Response of pediatric malignant solid tu

Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: A single hospital experience

✍ Pratt, Charles B.; Luo, Xiaolong; Fang, Lei; Marina, Neyssa; Avery, Loraine; Fur 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Cisplatin and ifosfamide with either vin

Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: The Institut Gustave Roussy experience

✍ Fadi Farhat; Stéphane Culine; Christine Théodore; Mohamed Békradda; Marie-Josée 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB 👁 2 views

## BACKGROUND. Approximately 30% of patients with metastatic germ cell tumors require salvage chemotherapy for recurrent or refractory disease after first-line treatment. The optimal salvage chemotherapy regimen remains to be determined. ## METHODS. Fifty-four patients with metastatic germ cell

Salvage therapy for non-Hodgkin's lympho

Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cisplatin

✍ Nissim Haim; Edward Rosenblatt; Mira Wollner; Menachem Ben-Shahar; Ron Epelbaum; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 236 KB

The role of ifosfamide plus cisplatin-ba

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

✍ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete